J&J submits BLA for Fibrin Pad

Johnson & Johnson (NYSE:JNJ) submitted a BLA to FDA for Fibrin Pad as an adjunct to hemostasis for soft tissue bleeding during surgery when control of bleeding by surgical methods of hemostasis is ine...